2nd Quarter - Report

ALKERMES, INC. for ALKERMES, INC.

Firm
Client
Income
—
Expenses
$750,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings; H.R. 955 - Medicaid Reentry Act of 2021; H.R. 1319 - American Rescue Plan Act of 2021 (PL 117-2) Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022; Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2022; Interior, Environment, and Related Agencies Appropriations Act, 2022; Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022;

LobbyistCovered position, as disclosed
ROBERT FORMAN —
WILLIAM PATRICK HIBBS New U.S. House of Representatives: Rep. Ryan Costello (2015-2018)
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL New U.S. House of Representatives: Rep. Jim Cooper (2008-2014), Rep. John Yarmuth (2014-2019)
PETER NORMAN —
KRISTI THOMPSON —

Contacted: Natl Institutes of Health (NIH); Veterans Affairs, Dept of (VA); Office of Natl Drug Control Policy (NDCP); Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 955 (117th), H.R. 1319 (117th)

Health Issues HCR

Awareness of the need for treatment system reform and access to all FDA-approved medications; Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments; Awareness of outcomes data and the need for training on all medication assisted treatment; H.R.1319 - American Rescue Plan Act of 2021 (PL 117-2);

LobbyistCovered position, as disclosed
WILLIAM PATRICK HIBBS New U.S. House of Representatives: Rep. Ryan Costello (2015-2018)
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL New U.S. House of Representatives: Rep. Jim Cooper (2008-2014), Rep. John Yarmuth (2014-2019)
PETER NORMAN —
KRISTI THOMPSON —

Contacted: Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); SENATE

Bills named: H.R. 1319 (117th)

Medicare/Medicaid MMM

Maintain six protected classes for depressions and schizophrenia under Medicare Part D; Seniors Prescription Drug Relief Act, S. 2327 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 19 - Lower Costs, More Cures Act

LobbyistCovered position, as disclosed
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL New U.S. House of Representatives: Rep. Jim Cooper (2008-2014), Rep. John Yarmuth (2014-2019)
PETER NORMAN —
KRISTI THOMPSON —

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); SENATE; Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Bills named: H.R. 19 (117th), H.R. 3 (117th), S. 2327 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.